Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PRKCA | P17252 | 7/20 | 0.81 |
| ▸ | ROCK2 | O75116 | 4/20 | 0.76 |
| ▸ | PRKCQ | Q04759 | 7/20 | 0.70 |
| ▸ | CDK4 | P11802 | 2/20 | 0.58 |
| ▸ | CCND1 | P24385 | 2/20 | 0.58 |
| ▸ | TOP1 | P11387 | 4/20 | 0.56 |
| ▸ | PRKD3 | O94806 | 3/20 | 0.56 |
| ▸ | PRKCG | P05129 | 3/20 | 0.56 |
| ▸ | PRKCB | P05771 | 3/20 | 0.56 |
| ▸ | PRKCH | P24723 | 3/20 | 0.56 |
| ▸ | PRKCI | P41743 | 3/20 | 0.56 |
| ▸ | PRKCE | Q02156 | 3/20 | 0.56 |
| ▸ | PRKCZ | Q05513 | 3/20 | 0.56 |
| ▸ | PRKCD | Q05655 | 3/20 | 0.56 |
| ▸ | PRKD1 | Q15139 | 3/20 | 0.56 |
| ▸ | CCNE2 | O96020 | 1/20 | 0.54 |
| ▸ | CCNE1 | P24864 | 1/20 | 0.54 |
| ▸ | CDK2 | P24941 | 1/20 | 0.54 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19050456 | 0.87 | PRKCQ (0.68) | PRKCAROCK2PRKCQCDK4CCND1 | |
| SCHEMBL5982059 | 0.87 | PRKCA (0.80) | PRKCATOP1 | |
| SCHEMBL10017808 | 0.86 | ROCK2 (1.00) | PRKCAROCK2PRKCQ | |
| SCHEMBL12570350 | 0.86 | ROCK2 (1.00) | PRKCAROCK2PRKCQ | |
| SCHEMBL15325110 | 0.86 | ROCK2 (1.00) | PRKCAROCK2PRKCQ | |
| SCHEMBL31691497 | 0.86 | ROCK2 (1.00) | PRKCAROCK2PRKCQ | |
| SCHEMBL30076664 | 0.86 | ROCK2 (1.00) | PRKCAROCK2PRKCQ | |
| SCHEMBL12570605 | 0.84 | PRKCQ (0.84) | PRKCAROCK2PRKCQCDK4CCND1 | |
| SCHEMBL12570348 | 0.84 | PRKCQ (0.84) | PRKCAROCK2PRKCQCDK4CCND1 | |
| SCHEMBL12570607 | 0.84 | PRKCQ (0.84) | PRKCAROCK2PRKCQCDK4CCND1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3184537-B1 | GLYCOSYLATED INDOLOCARBAZOLES, METHOD FOR OBTAINING SAME AND USES THEREOF | UNIV OVIEDO (ES) | 2020-07-08 | — | — | EP | disclosed |
| EP-3184537-A1 | GLYCOSYLATED INDOLOCARBAZOLES, METHOD FOR OBTAINING SAME AND USES THEREOF | Universidad De Oviedo (ES) | 2017-06-28 | — | — | EP | disclosed |
| EP-2277885-B1 | GLYCOSYLATED INDOLECARBAZOLES, METHOD FOR OBTAINING SAME AND USES THEREOF | UNIV OVIEDO (ES) | 2017-03-15 | — | — | EP | disclosed |
| US-20110136753-A1 | GLYCOSYLATED INDOLECARBAZOLES, METHOD FOR OBTAINING SAME AND USES THEREOF | UNIVERSIDAD DE OVIEDO (ES) | 2011-06-09 | — | — | US | disclosed |
| EP-2277885-A1 | GLYCOSYLATED INDOLECARBAZOLES, METHOD FOR OBTAINING SAME AND USES THEREOF | Universidad De Oviedo (ES) | 2011-01-26 | — | — | EP | disclosed |
| WO-2009125042-A1 | GLYCOSYLATED INDOLECARBAZOLES, METHOD FOR OBTAINING SAME AND USES THEREOF | UNIVERSIDAD DE OVIEDO (ES) | 2009-10-15 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110136753-A1 | GLYCOSYLATED INDOLECARBAZOLES, METHOD FOR OBTAINING SAME AND USES THEREOF | PYGB, INMT, SI | PRKCA 1688/4885ROCK2 315/4885PRKCQ 2262/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.